Michael Zdanowski
Corporate Officer/Principal at Medeor Therapeutics, Inc.
Net worth: 3 366 $ as of 2024-03-30
Profile
Michael Zdanowski is currently the Vice President-GMP Operations at New York Stem Cell Foundation, Inc. and the Senior VP-Biopharmaceutical Operations at Medeor Therapeutics, Inc. He was previously the Chief Technology Officer at Talaris Therapeutics, Inc. from 2020 to 2023.
He received an undergraduate degree from the University of Pennsylvania and an MBA from Columbia University School of the Arts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.00% | 2023-04-16 | 147 ( 0.00% ) | 3 366 $ | 2024-03-30 |
Michael Zdanowski active positions
| Companies | Position | Start |
|---|---|---|
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| New York Stem Cell Foundation, Inc. | Corporate Officer/Principal | - |
Former positions of Michael Zdanowski
| Companies | Position | End |
|---|---|---|
| TOURMALINE BIO, INC. | Chief Tech/Sci/R&D Officer | 2023-04-27 |
Training of Michael Zdanowski
| University of Pennsylvania | Undergraduate Degree |
| Columbia University School of the Arts | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| New York Stem Cell Foundation, Inc. | Miscellaneous |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
- Stock Market
- Insiders
- Michael Zdanowski
